Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Clinical trial NCT02393794 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02393794
- Sponsor
- Priyanka Sharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-17
- Primary completion
- 2026-07-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.